Latest News about atopic dermatitis
Recent news which mentions atopic dermatitis
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
May 16, 2024
Tickers
JNJ
NEWS
SWAV
Tags
General
Benzinga
Stories That Matter
From
Benzinga
Eli Lilly Reveals More Phase 3 Data From Lebrikizumab Trial In Atopic Dermatitis
April 11, 2022
Tickers
LLY
Tags
Large Cap
News
Health Care
From
Benzinga
VYNE Therapeutics Shares Gain After Positive Atopic Dermatitis Trial Of FMX114
April 07, 2022
Tickers
VYNE
Tags
Phase 2 Trial
General
VYNE
From
Benzinga
Sanofi - Regeneron's Dupixent Under FDA Priority Review For Children Under 5 Years With Atopic Dermatitis
February 10, 2022
Tickers
REGN
SNY
Tags
General
FDA
Market News
From
Benzinga
ASLAN Pharma Kickstarts Mid-Stage Atopic Dermatitis Trial, Data Expected In 2023
January 21, 2022
Tickers
ASLN
Tags
Market News
News
Penny Stocks
From
Benzinga
FDA Approves AbbVie's Upadacitinib For Refractory Atopic Dermatitis In Patients 12 Years & Older
January 18, 2022
Tickers
ABBV
Tags
Briefs
Guidance
News
From
Benzinga
EXCLUSIVE: Hoth Therapeutics Starts Dosing In Second Cohort Of Atopic Dermatitis Trial With BioLexa
November 30, 2021
Tickers
HOTH
Tags
atopic dermatitis
Biotech
Benzinga
From
Benzinga
Connect Biopharma's Mid-Stage Atopic Dermatitis Trial Meets Primary Endpoint
November 19, 2021
Tickers
CNTB
Tags
Health Care
Trading Ideas
News
From
Benzinga
AbbVie Presents New Upadacitinib Data In Atopic Dermatitis
September 30, 2021
Tickers
ABBV
Tags
Biotech
atopic dermatitis
ABBV
From
Benzinga
Pfizers' JAK Inhibitor Approved In Japan For Atopic Dermatitis
September 30, 2021
Tickers
PFE
Tags
Briefs
News
PFE
From
Benzinga
Why Did ASLAN Pharma Shares Plunge Despite Positive Atopic Dermatitis Trial Data?
September 27, 2021
Tickers
ASLN
Tags
Penny Stocks
Trading Ideas
Phase 1 Trial
From
Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
September 22, 2021
Tickers
INCY
Tags
Market News
News
Health Care
From
Benzinga
Pfizer's Abrocitinib Beats Dupixent Late-stage Eczema Trial
August 30, 2021
Tickers
PFE
REGN
SNY
Tags
Health Care
News
SNY
From
Benzinga
Dupixent Becomes First Biologic To Show Benefit In Infant Patients With Atopic Dermatitis
August 30, 2021
Tickers
REGN
SNY
Tags
General
Market News
SNY
From
Benzinga
Lilly's Lebrikizumab Shows Clinical Benefit In Late-Stage Atopic Eczema Trials
August 16, 2021
Tickers
LLY
Tags
Benzinga
Phase 3 Trial
Health Care
From
Benzinga
VYNE Therapeutics Stock Drops On Potential Sale Of Topical Minocycline Franchise
August 12, 2021
Tickers
VYNE
Tags
News
inflammatory diseases
Short Ideas
From
Benzinga
FDA Will Not Meet Goal Dates For Pfizer's Xeljanz, Abrocitinib Applications
July 22, 2021
Tickers
PFE
Tags
spondylitis
Market News
General
From
Benzinga
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
July 16, 2021
Tickers
ABBV
INCY
LLY
Tags
News
Briefs
INCY
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.